Statistics
Publications
1
Citations
28
H-Index
1
Active since
2022
Affiliations
Zongwen Wang is an author at Fourth Affiliated Hospital of Harbin Medical University specializing in reversal of drug resistance, expression profiling, and molecular tumor profiling.
Publications per year
2022–2022
1
1
TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.
Zongwen Wang, Qiankun Zhu, Xiaodong Li et al. · PubMed · 2022 · 28 citations · Full text
Medicine, Oncology, Pharmacology +17
1–1 of 1